Lactose India (LACTOSE) | Financial Analysis & Statements
Lactose India Ltd. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
395.8M
Gross Profit
101.3M
25.58%
Operating Income
30.9M
7.82%
Net Income
15.0M
3.79%
EPS (Diluted)
₹1.16
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
747.3M
Shareholders Equity
587.4M
Debt to Equity
1.27
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Lactose India Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 649.1M | 451.0M | 343.1M |
| Cost of Goods Sold | 772.1M | 750.1M | 413.8M | 156.7M | 121.0M |
| Gross Profit | 390.6M | 387.8M | 235.3M | 294.4M | 222.1M |
| Gross Margin % | 33.6% | 34.1% | 36.2% | 65.3% | 64.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 59.0M | 46.6M | 19.4M | 9.4M | 10.0M |
| Other Operating Expenses | 37.4M | 45.4M | 29.5M | 32.3M | 30.0M |
| Total Operating Expenses | 96.4M | 92.0M | 48.8M | 41.8M | 40.1M |
| Operating Income | 115.9M | 137.9M | 66.9M | 77.3M | 23.8M |
| Operating Margin % | 10.0% | 12.1% | 10.3% | 17.1% | 6.9% |
| Non-Operating Items | |||||
| Interest Income | 6.7M | 3.8M | 3.5M | 2.1M | 1.5M |
| Interest Expense | 52.7M | 52.4M | 59.5M | 51.0M | 54.3M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 69.2M | 96.6M | 14.6M | 31.7M | -32.7M |
| Income Tax | 17.5M | 28.8M | 2.6M | 7.1M | -7.9M |
| Effective Tax Rate % | 25.4% | 29.7% | 17.5% | 22.6% | 0.0% |
| Net Income | 51.6M | 67.9M | 12.1M | 24.5M | -24.8M |
| Net Margin % | 4.4% | 6.0% | 1.9% | 5.4% | -7.2% |
| Key Metrics | |||||
| EBITDA | 175.4M | 201.1M | 120.7M | 127.3M | 69.7M |
| EPS (Basic) | ₹4.10 | ₹5.39 | ₹0.96 | ₹2.10 | ₹-2.40 |
| EPS (Diluted) | ₹4.06 | ₹5.39 | ₹0.96 | ₹2.10 | ₹-2.40 |
| Basic Shares Outstanding | 12589000 | 12589000 | 12589000 | 11683921 | 10312090 |
| Diluted Shares Outstanding | 12589000 | 12589000 | 12589000 | 11683921 | 10312090 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Lactose India Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 44.8M | 15.3M | 5.8M | 19.2M | 21.6M |
| Short-term Investments | 5.4M | 4.6M | 1.6M | 500.0K | 4.7M |
| Accounts Receivable | 216.4M | 154.0M | 107.7M | 38.6M | 64.3M |
| Inventory | 245.5M | 167.9M | 227.8M | 71.2M | 83.2M |
| Other Current Assets | 60.0K | 13.6M | 9.3M | 3.0K | 10.1M |
| Total Current Assets | 573.3M | 355.3M | 374.0M | 227.5M | 197.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 12.7M | 12.7M | 12.7M | 12.7M | 12.7M |
| Goodwill | 526.0K | 568.0K | 91.0K | 186.0K | 280.0K |
| Intangible Assets | 526.0K | 568.0K | 91.0K | 186.0K | 280.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 284.1M | 32.5M | 25.1M | 23.9M | 2.0K |
| Total Non-Current Assets | 761.4M | 652.1M | 638.9M | 674.7M | 686.4M |
| Total Assets | 1.3B | 1.0B | 1.0B | 902.2M | 883.4M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 106.4M | 83.0M | 182.3M | 40.4M | 21.7M |
| Short-term Debt | 308.9M | 143.8M | 58.2M | 68.3M | 65.5M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.0K | 6.3M | -2.0K | -1.0K | 1.0K |
| Total Current Liabilities | 448.9M | 254.0M | 264.7M | 149.1M | 116.3M |
| Non-Current Liabilities | |||||
| Long-term Debt | 259.3M | 248.8M | 326.5M | 344.9M | 395.9M |
| Deferred Tax Liabilities | 23.2M | 19.0M | 6.8M | 5.8M | 4.6M |
| Other Non-Current Liabilities | 2.9M | 3.2M | -2.0K | - | -1.0K |
| Total Non-Current Liabilities | 298.4M | 282.4M | 342.6M | 360.3M | 416.3M |
| Total Liabilities | 747.3M | 536.4M | 607.3M | 509.4M | 532.6M |
| Equity | |||||
| Common Stock | 125.9M | 125.9M | 125.9M | 125.9M | 114.4M |
| Retained Earnings | 260.0M | 208.4M | 140.5M | 128.4M | 103.9M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 587.4M | 471.0M | 405.6M | 392.8M | 350.9M |
| Key Metrics | |||||
| Total Debt | 568.3M | 392.5M | 384.7M | 413.3M | 461.5M |
| Working Capital | 124.4M | 101.3M | 109.3M | 78.4M | 80.8M |
Balance Sheet Composition
Lactose India Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 69.2M | 96.6M | 14.6M | 31.7M | -32.7M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -169.6M | 7.7M | -171.6M | -64.8M | -27.9M |
| Operating Cash Flow | -49.1M | 156.0M | -97.9M | 16.6M | -7.7M |
| Investing Activities | |||||
| Capital Expenditures | -139.2M | -21.6M | -15.1M | -10.3M | -54.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | -235.0K | -8.7M |
| Investment Sales | - | - | - | 3.5M | - |
| Investing Cash Flow | -139.2M | -21.6M | -15.1M | -7.1M | -63.3M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 65.2M | 66.1M | -7.8M | 4.2M | 43.8M |
| Free Cash Flow | -146.7M | 65.9M | 63.3M | 71.4M | -33.2M |
| Net Change in Cash | -123.0M | 200.4M | -120.8M | 13.8M | -27.1M |
Cash Flow Trend
Lactose India Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.45
Price to Book
2.38
Price to Sales
1.02
PEG Ratio
0.21
Profitability Ratios
Profit Margin
3.32%
Operating Margin
4.45%
Return on Equity
8.79%
Return on Assets
3.87%
Financial Health
Current Ratio
1.26
Debt to Equity
86.78
Beta
0.38
Per Share Data
EPS (TTM)
₹3.86
Book Value per Share
₹49.43
Revenue per Share
₹118.11
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LACTOSE | 1.5B | 30.45 | 2.38 | 8.79% | 3.32% | 86.78 |
| Sun Pharmaceutical | 3.9T | 36.73 | 5.15 | 15.08% | 19.21% | 6.68 |
| Divi's Laboratories | 1.7T | 67.11 | 10.82 | 14.64% | 24.04% | 0.58 |
| Sun Pharma Advanced | 46.7B | -13.65 | -13.55 | 157.88% | -53.22% | -1.21 |
| Innova Captab | 41.4B | 31.20 | 4.05 | 13.37% | 8.85% | 32.95 |
| Gujarat Themis | 35.4B | 73.73 | 13.36 | 19.64% | 29.99% | 27.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.





